TableĀ 2

Paralogue annotation of novel variants identified in RYR2

RYR2 variant
CDSProteinRegionCases (n=155)ExonParalogueParalogue variantParalogue diseaseConsensus
c.527G>Ap.R176QN-terminal hotspot18RYR1R163LMalignant hyperthermia9
RYR1R163CCentral core disease9
c.994C>Tp.R332WN-terminal hotspot112RYR1R316LMalignant hyperthermia8
c.1069G>Ap.G357SN-terminal hotspot113RYR1G341RMalignant hyperthermia9
RYR1G341RMalignant hyperthermia9
c.1646C>Tp.A549VOutside hotspots117RYR1A537TCongenital myopathy9
c.6504C>Gp.H2168QOutside hotspots242RYR1H2204QMultiminicore disease9
c.7258A>Tp.R2420WCentral hotspot148RYR1R2454CMalignant hyperthermia9
RYR1R2454HMalignant hyperthermia9
c.11989A>Gp.K3997EChannel hotspot190RYR1R4041WMalignant hyperthermia9
c.14369G>Ap.R4790QChannel hotspot1100RYR1R4861CCentral core disease9
RYR1R4861HCentral core disease9
c.14414A>Gp.K4805RChannel hotspot1100RYR1K4876RMalignant hyperthermia9
c.14465G>Ap.R4822HChannel hotspot1101RYR1R4893WCentral core disease9
RYR1R4893QCentral core disease9
RYR1R4893PCentral core disease9
  • Ten out of 31 novel missense variants identified in 155 unrelated CPVT patients10 were annotated. This provides strong evidence of pathogenicity for these variants. In addition, five of the 29 RYR2 missense variants previously reported to be pathogenic were annotated (see supplementary table S1, available online only).

  • RYR2 coordinates given with respect to transcripts NM_001035/NP_001026 (Refseq), ENST00000366574/ENSP00000355533 (Ensembl), LRG_402t1/LRG_402p1 (Locus Reference Genomic).

  • CDS, coding DNA sequence; CPVT, catecholaminergic polymorphic ventricular tachycardia.